Secondary metabolites from Lobaria pulmonaria (L.) Hoffm. target key metabolic enzymes: a novel strategy against multidrug-resistant tuberculosis
Open Access
- 11 February 2026
- journal article
- research article
- Published by Royal Society of Chemistry (RSC) in RSC Advances
- Vol. 16 (10) , 8960-8970
Abstract
Numerous cultures have traditionally utilised the foliose lichen Lobaria pulmonaria (L.) Hoffm. (“Oak Lung” or “Lungs of Oak” in English; family: Lobariaceae) as a Tuberculosis (Tb) treatment.Keywords
This publication has 45 references indexed in Scilit:
- Bioassay-guided isolation of antimycobacterial substances from the traditionally used lichen Cladonia pyxidata (L.) Hoffm.3 Biotech, 2022
- Handbook of Tuberculosis2017
- Gastroprotective and Antioxidant Effects of Lobaria pulmonaria and Its Metabolite Rhizonyl Alcohol on Indomethacin‐Induced Gastric UlcerChemistry & Biodiversity, 2015
- Lichenology: Current Research in India2015
- Lichens Used in Traditional Medicine2014
- AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibilityJournal of Computational Chemistry, 2009
- The effects of methanol extract of Lobaria pulmonaria, a lichen species, on indometacin‐induced gastric mucosal damage, oxidative stress and neutrophil infiltrationPhytotherapy Research, 2008
- Automated docking using a Lamarckian genetic algorithm and an empirical binding free energy functionJournal of Computational Chemistry, 1998
- Identification of Lichen Substances1996
- ANTIBIOTICS IN LICHENS1973